I don't think you understand how an SPP works. All shareholders face the same $ limit (eg $30,000 maximum) and frequently are scaled back. A small investor say with $100,000 invested whose application for $30k is scaled back to $10k increases their holding in the company by 10%. A large investor say with $5m invested would only increase their exposure to the company by a maximum amount of $30k (even if no scaling) which is less than 1% increase - so your assertion that it would further dilute the small investor is nonsense.
Only those who do not participate will be diluted and that is exactly what has happened with the past few raises. The difference being existing shareholders are being offered the chance to participate rather than watching the discounted offerings and free options being gifted to new investors - some of whom are very quick to take their quick profits and walk away.
- Forums
- ASX - By Stock
- A timeline going forward would be greatly appreciated
AVR
anteris technologies global corp.
Add to My Watchlist
6.09%
!
$6.27

I don't think you understand how an SPP works. All shareholders...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M |
Open | High | Low | Value | Volume |
$5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | $6.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.27 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 6.120 |
1 | 2000 | 6.100 |
1 | 1000 | 6.000 |
1 | 1250 | 5.950 |
1 | 857 | 5.830 |
Price($) | Vol. | No. |
---|---|---|
6.270 | 200 | 1 |
6.300 | 463 | 1 |
6.400 | 130 | 1 |
6.500 | 255 | 1 |
6.550 | 1092 | 1 |
Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online